141 related articles for article (PubMed ID: 21397778)
1. Medication adherence affects treatment modifications in patients with type 2 diabetes.
Voorham J; Haaijer-Ruskamp FM; Wolffenbuttel BH; Stolk RP; Denig P;
Clin Ther; 2011 Jan; 33(1):121-34. PubMed ID: 21397778
[TBL] [Abstract][Full Text] [Related]
2. Refill adherence and polypharmacy among patients with type 2 diabetes in general practice.
van Bruggen R; Gorter K; Stolk RP; Zuithoff P; Klungel OH; Rutten GE
Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):983-91. PubMed ID: 19623570
[TBL] [Abstract][Full Text] [Related]
3. [Trends in subclinical atherosclerosis in patients with arterial hypertension associated with diabetes mellitus: a relationship between blood pressure achieved with antihypertensive therapy and body weight].
Karpov RS; Koshel'skaia OA; Khoroshilova IV
Ter Arkh; 2010; 82(9):23-30. PubMed ID: 21086616
[TBL] [Abstract][Full Text] [Related]
4. [Inadequate treatment and control of arterial hypertension in patients with type 2 diabetes mellitus].
Boero R; Prodi E; Borsa S; Berti V; Fiorio E; Ferraro L; Massara C; Quarello F
G Ital Nefrol; 2002; 19(4):413-8. PubMed ID: 12369043
[TBL] [Abstract][Full Text] [Related]
5. The goal blood pressure in type 2 diabetes: do we have an ACCORD?
Crouch MA
Consult Pharm; 2010 Oct; 25(10):686, 688. PubMed ID: 21030359
[No Abstract] [Full Text] [Related]
6. [Type 2 diabetic patients with hypertension: do they prefer treating diabetes or hypertension?].
El Aassri H; El Mghari G; El Ansari N
Pan Afr Med J; 2014; 17():193. PubMed ID: 25396019
[TBL] [Abstract][Full Text] [Related]
7. Global cardiometabolic risk profile in patients with hypertension: results from the Turkish arm of the pan-European GOOD survey.
Kabakcı G; Aydın M; Demir I; Kırma C; Özerkan F
Turk Kardiyol Dern Ars; 2010 Jul; 38(5):313-20. PubMed ID: 21200100
[TBL] [Abstract][Full Text] [Related]
8. Relationship of blood pressure control and hospitalization risk to medication adherence among patients with hypertension in Taiwan.
Wu PH; Yang CY; Yao ZL; Lin WZ; Wu LW; Chang CC
Am J Hypertens; 2010 Feb; 23(2):155-60. PubMed ID: 19927135
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic compliance in patients with arterial hypertension and type 2 diabetes mellitus].
Gutiérrez-Angulo ML; Lopetegi-Uranga P; Sánchez-Martín I; Garaigordobil-Landazabal M
Rev Calid Asist; 2012; 27(2):72-7. PubMed ID: 22138203
[TBL] [Abstract][Full Text] [Related]
10. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
11. Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).
Gudbjörnsdottir S; Eeg-Olofsson K; Cederholm J; Zethelius B; Eliasson B; Nilsson PM;
Diabet Med; 2009 Jan; 26(1):53-60. PubMed ID: 19125761
[TBL] [Abstract][Full Text] [Related]
12. Rapid reduction of antihypertensive medications and insulin requirements after tracheostomy in a patient with severe obstructive sleep apnea syndrome.
Bhimaraj A; Havaligi N; Ramachandran S
J Clin Sleep Med; 2007 Apr; 3(3):297-9. PubMed ID: 17561601
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
14. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
Hertz RP; Unger AN; Lustik MB
Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
[TBL] [Abstract][Full Text] [Related]
15. [Guidelines for the treatment of arterial hypertension in diabetes mellitus. The consensus recommendations of the German League for the Fight against High Blood Pressure, Inc., the German Diabetes Society and the Society for Nephrology].
Schäfers RF; Lütkes P; Ritz E; Philipp T
Dtsch Med Wochenschr; 1999 Nov; 124(45):1356-72. PubMed ID: 10592780
[No Abstract] [Full Text] [Related]
16. Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents.
Kalsekar ID; Madhavan SS; Amonkar MM; Makela EH; Scott VG; Douglas SM; Elswick BL
Ann Pharmacother; 2006 Apr; 40(4):605-11. PubMed ID: 16551768
[TBL] [Abstract][Full Text] [Related]
17. [Blood pressure and type 2 diabetes mellitus: impact of the insulin therapy].
Dakhli S; Lamine S; Lamine F; Trabelsi N; Aouididi F; Zouaoui C; Mami FB; Achour A
Tunis Med; 2007 Nov; 85(11):945-50. PubMed ID: 19166146
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone shift circadian rhythm of blood pressure from non-dipper to dipper type in type 2 diabetes mellitus.
Anan F; Masaki T; Fukunaga N; Teshima Y; Iwao T; Kaneda K; Umeno Y; Okada K; Wakasugi K; Yonemochi H; Eshima N; Saikawa T; Yoshimatsu H
Eur J Clin Invest; 2007 Sep; 37(9):709-14. PubMed ID: 17696960
[TBL] [Abstract][Full Text] [Related]
20. [Arterial hypertension management in patients with type 2 diabetes].
Charpentier G; Genès N; Vaur L; Clerson P; Amar J; Guéret P; Cambou JP
Arch Mal Coeur Vaiss; 2002; 95(7-8):661-5. PubMed ID: 12365076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
